Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTUncompromising renal + sensitivities care.Managing pain from canine OA doesn’t have to be complicated. Discover an approach that doesn’t just treat pain, but addresses inflammation, too. + Learn More